Class Action Filed Against BioAge Labs Over Securities Fraud Claims
LOS ANGELES
,
March 10, 2025
/PRNewswire/ — The Schall Law Firm, a prominent national firm focused on shareholder rights litigation, has initiated a class action lawsuit against BioAge Labs, Inc. (“BioAge” or “the Company”) (BIOA) for alleged violations of federal securities laws.
Investors who bought the Company’s securities related to its initial public offering (“IPO”) launched on September 26, 2024, are urged to reach out to the firm before March 10, 2025.
If you are a shareholder who experienced financial loss, click here to participate.
For further assistance, contact Brian Schall at the Schall Law Firm, located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or call 310-301-3335 for a free consultation. You can also visit our website at www.schallfirm.com, or email at [email protected].
Please note that the class action has not yet been certified. Without this certification, you do not have representation. If no action is taken, you will remain an absent class member.
The Complaint alleges that BioAge issued false and misleading statements. Notably, the Company announced on December 6, 2024, that it would terminate its STRIDES Phase 2 trial of its key candidate, azelaprag, due to safety concerns. This contradicts earlier assertions made during the IPO regarding azelaprag’s potential in obesity therapy alongside incretin drugs. Consequently, the Company’s public statements were found to be false and materially misleading, leading to losses for investors once the truth emerged about BioAge.
To join the case and seek compensation for your losses, follow the appropriate channels.
The Schall Law Firm assists investors globally, focusing on securities class action lawsuits and protecting shareholder rights.
This press release may be regarded as Attorney Advertising in certain jurisdictions under relevant laws and ethical standards.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]
View original content to download multimedia: here.
SOURCE: The Schall Law Firm